These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6157734)

  • 1. Effect of dextran-S (alpha, 1-3 dextran) on the growth of plasmacytomas MOPC-104E and J558.
    Bhoopalam N; Heller P; Meyerstein N; Hall L
    J Immunol; 1980 Oct; 125(4):1454-8. PubMed ID: 6157734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isogeneic monoclonal antibodies against anti-alpha(1----3)dextran idiotypes. I. Isotypes, idiotope specificity and representation of idiotopes in antisera from mice of various genetic constitutions.
    Wilke J; Weiler E
    Eur J Immunol; 1987 Feb; 17(2):255-60. PubMed ID: 2435560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface immunoglobulins of lymphocytes in plasmacytoma. V. The effect of RNA-rich extract from mouse plasmacytoma MOPC 104E on the immune response.
    Bhoopalam N; Chen Y; Yakulis V; Heller P
    Clin Exp Immunol; 1976 May; 24(2):357-67. PubMed ID: 1277583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immune response to sheep red blood cells on plasmacytoma MOPC 104 E.
    Ghanta VK; Hiramoto NS; Hiramoto RN
    Cancer Res; 1981 Jun; 41(6):2197-9. PubMed ID: 7237419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appearance of a variant of MOPC 104E which does not react with dextran B-1355s.
    Folds JD
    Immunol Commun; 1977; 6(4):385-94. PubMed ID: 407151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of tumor growth and antibody clone expression by antigen and anti-idiotype antibody ligands with specificity for receptor-binding sites.
    Bell C; Klein E
    Eur J Immunol; 1979 Oct; 9(10):762-8. PubMed ID: 520408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies.
    Kodama K; Ghanta VK; Hiramoto NS; Hiramoto RN
    J Biol Response Mod; 1989 Aug; 8(4):385-96. PubMed ID: 2754437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth of MOPC 104E cells in immunosuppressed mice.
    Hiramoto RN; Cox PJ; Hiramoto NS; Ghanta VK
    J Immunol; 1984 Dec; 133(6):3424-8. PubMed ID: 6386985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of monoclonal anti-idiotype antibodies (anti-M104E) on MOPC 104E myeloma cells.
    Kodama K; Ghanta VK; Hiramoto RN; Stohrer RC; Kearney JF
    Cancer Res; 1986 Mar; 46(3):1250-4. PubMed ID: 3484677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104E.
    Hayashida I; Hiramoto RN; Shrestha K; Ghanta VK
    Cancer Invest; 1989; 7(1):17-26. PubMed ID: 2567619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal complement depletion results in predominant expression of a myeloma M 104E private idiotope among anti-dextran antibodies.
    Weiler E; Lehle G
    Eur J Immunol; 1991 May; 21(5):1207-12. PubMed ID: 1709869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a cross-reactive idiotype dextran-positive antibody response in two IgH-Cb mouse strains treated with anti-J558 cross-reactive idiotype antibodies.
    Pène J; Bekkhoucha F; Desaymard C; Zaghouani H; Stanislawski M
    J Exp Med; 1983 May; 157(5):1573-93. PubMed ID: 6189941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
    Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
    Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte surface membrane immunoglobulin in myeloma. II. T cells with IgA-Fc receptors are markedly increased in mice with IgA plasmacytomas.
    Hoover RG; Lynch RG
    J Immunol; 1980 Sep; 125(3):1280-8. PubMed ID: 6967897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. I. Methodological studies on the Winn assay.
    Wang KC; Berczi I; Sehon AH
    Int J Cancer; 1980 Apr; 25(4):487-92. PubMed ID: 7372372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA anti-dextran B1355 responses.
    Kagnoff MF
    J Immunol; 1979 Mar; 122(3):866-70. PubMed ID: 109506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
    Mathur A; Lynch RG
    J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of MOPC 104E by T cells and growth factors induced by C. parvum stimulation.
    Shrestha K; Hiramoto RN; Ghanta VK
    Int J Cancer; 1984 Jun; 33(6):845-50. PubMed ID: 6610653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
    Flood PM; Philipps C; Taupier MA; Schreiber H
    J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.